PROCOVA Trademark

Trademark Overview


On Tuesday, October 19, 2021, a trademark application was filed for PROCOVA with the United States Patent and Trademark Office. The USPTO has given the PROCOVA trademark a serial number of 97081487. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, July 23, 2024. This trademark is owned by UNLEARN.AI, INC.. The PROCOVA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

providing medical and scientific research information in the fields of medical research, pharmaceutical development and clinical trials; consulting services for others in the field of design and planning of clinical trials; consulting services for others in the fields of medical research and pharmaceutical development; consulting services for others in the fields of medical research and pharmaceutical development, namely, providing digital models of patients for use as simulated control subjects; consulting services for others in the field of design and planning of clinical trials, namely, providing digital models of patients for use as simulated control subjects for clinical trials; providing online non-downloadable software featuring artificial intelligence for data analytics for use in the design and planning of clinical trials; providing online non-downloadable software featuring artificial intelligence for data analytics for use in medical research and pharmaceutical development; ...
procova

General Information


Serial Number97081487
Word MarkPROCOVA
Filing DateTuesday, October 19, 2021
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, July 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 28, 2023

Trademark Statements


Pseudo MarkPRO COVA
Goods and Servicesproviding medical and scientific research information in the fields of medical research, pharmaceutical development and clinical trials; consulting services for others in the field of design and planning of clinical trials; consulting services for others in the fields of medical research and pharmaceutical development; consulting services for others in the fields of medical research and pharmaceutical development, namely, providing digital models of patients for use as simulated control subjects; consulting services for others in the field of design and planning of clinical trials, namely, providing digital models of patients for use as simulated control subjects for clinical trials; providing online non-downloadable software featuring artificial intelligence for data analytics for use in the design and planning of clinical trials; providing online non-downloadable software featuring artificial intelligence for data analytics for use in medical research and pharmaceutical development; providing online non-downloadable software featuring artificial intelligence for data analytics for use in the life sciences field, for the purposes of research, development, and commercialization; providing a website featuring educational information in the fields of medical research, pharmaceutical development, clinical trials and artificial intelligence software technologies

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 5, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameUNLEARN.AI, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94107

Party NameUNLEARN.AI, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94105

Trademark Events


Event DateEvent Description
Friday, October 22, 2021NEW APPLICATION ENTERED
Friday, November 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 26, 2022ASSIGNED TO EXAMINER
Tuesday, July 26, 2022NON-FINAL ACTION WRITTEN
Tuesday, July 26, 2022NON-FINAL ACTION E-MAILED
Tuesday, February 7, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 7, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, February 7, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 7, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, March 2, 2023NON-FINAL ACTION WRITTEN
Thursday, March 2, 2023NON-FINAL ACTION E-MAILED
Thursday, March 2, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 3, 2023NON-FINAL ACTION WRITTEN
Friday, March 3, 2023NON-FINAL ACTION E-MAILED
Friday, March 3, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 12, 2023ASSIGNED TO LIE
Tuesday, September 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 23, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, February 23, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 28, 2023PUBLISHED FOR OPPOSITION
Friday, February 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 23, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 23, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 23, 2024SOU EXTENSION 1 FILED
Tuesday, July 23, 2024SOU EXTENSION 1 GRANTED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED